December 2025 monthly summary for hartwigmedical/scripts: Focused on aligning data sources to support NCR Analytics with up-to-date data access and improved analytics reliability.

March 2025 monthly summary: Implemented ACTIN Personalization Database Setup Enhancement by integrating Python-based data processing into the existing SQL-centric workflow, enabling streamlined creation and loading of the personalization database and automated aggregation of distant metastasis overview data. This change improves setup reproducibility, data quality, and overall automation of the data pipeline.

February 2025 monthly summary for hartwigmedical/scripts: Delivered the Actin Cairo SQL Command Executor Script, a Bash-based tool that centralizes SQL execution against the actin_cairo database using production writer credentials. The script standardizes how SQL files or statements are run, improving consistency, security, and auditability of database interactions. This focused feature work reduces manual errors and lays the foundation for broader SQL automation across environments. No major bugs were fixed this month; emphasis was on delivering robust automation, code quality, and maintainability. Technologies demonstrated include Bash scripting, SQL execution, credential handling, and automation patterns.

January 2025 monthly summary for hartwigmedical/actin: Focused on dependency management to ensure alignment with the latest actin-personalization version. Updated the actin-personalization dependency with no code changes, maintaining existing functionality while improving security and compatibility. Commit applied: c1b519ea106270c2b5ef487f3b32f97b34cf1b83.

November 2024 (hartwigmedical/actin): Delivered No-Treatment group integration and None-Treatment handling to extend data modeling and analysis for all treatment arms; enhanced Real-World survival reporting with OS included in Real-World outcomes and SOC table, plus front-page OS visibility. Removed None as a treatment option to enforce valid selections. Implemented UI/table layout improvements and comprehensive test updates to ensure reliability. The work aligns with ACTIN-1348 objectives, driving richer real-world insights and more robust presentation of outcomes for stakeholders.

October 2024 - Actin (hartwigmedical/actin): Delivered the core Overall Survival (OS) metrics capability for the Treatment Report. The changes enable survival analysis by adjusting data structures and aligning report generation with OS data flows, providing stakeholders with survival-informed treatment insights. This work centers on the ACTIN-1348 initiative and was implemented in the repository with the commit 126a37d09e2758f75c1fb78b7bb820de803d8f01 (Add OS to report).